...
机译:在不成功的Daclatasvir / AsunaPrevir治疗后,用或没有引入干扰素-β注射患者的患者与Sofosbuvir / LEDIPASVIR进行再处理
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
Department of Gastroenterology and Hepatology Faculty of MedicineSaitama Medical UniversitySaitama;
asunaprevir; daclatasvir; interferon‐β; ledipasvir; NS5A‐RAS; sofosbuvir;
机译:在不成功的Daclatasvir / AsunaPrevir治疗后,用或没有引入干扰素-β注射患者的患者与Sofosbuvir / LEDIPASVIR进行再处理
机译:达卡他韦加阿舒那普韦在亚洲慢性丙型肝炎病毒基因型1b感染患者中进行或不接受或不接受利巴韦林干扰素阿尔法治疗的3期开放标签研究
机译:慢性丙型肝炎基因型1患者Sofosbuvir / LEDIPASVIR临床评价及未经证实的daclatasvir / Asunaprevir治疗
机译:HLA-C基因在丙型肝炎病毒中感染埃及患者,估计HLA-C基因和干扰素/利巴韦林与丙型肝炎病毒治疗的关系
机译:索非布韦联合莱替帕韦成功治愈了基因型1b丙型肝炎肝硬化患者该患者中止了先前的Asunaprevir和daclatasvir联合治疗:一个病例系列和文献复习
机译:在没有基线NS5A多态性的丙型肝炎病毒基因型1b的老年和肝硬化患者中,对达卡他韦加Asunaprevir的高持续病毒学应答